Teva Pharmaceutical Industries Ltd (ADR) TEVA shares are trading lower by $6.90 (22 percent) at $24.36 in Thursday's session.
Before the open, Teva reported a Q2 EPS miss of 4 cents along with a slight sales miss. The company trimmed its FY 2017 outlook and slashed its dividend from $0.34 to $0.085 per share.
After a lower open, Teva had a 62-cent bounce to $26.37 before resuming its steep decline. It has continued to make lows for the session, with the current one standing at $24.27 as of 12:25 p.m. EST. That marks the lowest level for the stock since November 2004, when it bottomed at $22.82.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.